Expression analysis of protein tyrosine kinases of the FAK (focal adhesion kinase) family in osteosarcoma;Untersuchungen zur expression von proteintyrosinkinasen der FAK-(focal adhesion kinase-) familie in Osteosarkomen

Pathologe

Volumn 23, Issue 5, 2002, Pages 361-366

  Schroder A ^a   Delling, G ^a   Kaiser, E ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Focal adhesion kinase (FAK); Immunohistochemistry; Osteoblast; Osteosarcoma; Real time PCR

Indexed keywords

FOCAL ADHESION KINASE; FOCAL ADHESION KINASE 2; PROLINE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CANCER GRADING; CARCINOGENESIS; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; FEMUR; GENE OVEREXPRESSION; HUMAN; HUMERUS; IMMUNOHISTOCHEMISTRY; MALE; NEWBORN; OSTEOBLAST; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; TIBIA; TUMOR LOCALIZATION;

EID: 0036919556     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-002-0557-x     Document Type: Article

References (34)

1. Werner M, Fuchs N, Salzer-Kuntschik M, Winkler K, Delling G (1996) Therapy-induced changes in osteosarcoma after neoadjuvant chemotherapy (COSS 86 Therapy Study). Correlation between morphologic findings and clinical follow-up. Pathologe 17:35-43
2. Delling G (1998) Diagnosis of bone tumors. Verh Dtsch Ges Pathol 82:121-132
3. Pollandt K, Engel C, Kaiser E, Werner M, Delling G (2001) Gsa gene mutations in monostotic fibrous dysplasia of bone and fibrous dysplasia-like low-grade central osteosarcoma. Virchows Arch 439:170-175
4. Bruland OS, Pihl A (1997) On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy. Eur J Cancer 33:1725-1731
5. Fuchs N, Bielack SS, Epler D et al. (1998) Longterm results of the co-operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 9:893-899
6. Khanna C, Khan J, Nguyen P et al. (2001) Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res 61:3750-3759
7. Schaller MD, Borgman CA, Cobb BS, Vines RR, Reynolds AB, Parsons JT (1992) pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci USA 89:5192-5196
8. Lev S, Moreno H, Martinez R et al. (1995) Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions. Nature 376:737-745
9. Schlaepfer DD, Hauck CR, Sieg DJ (1999) Signaling through focal adhesion kinase. Prog Biophys Mol Biol 71:435-478
10. Avraham S, London R, Fu Y et al. (1995) Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain. J Biol Chem 270:27742-27751
11. Du QS, Ren XR, Xie Y, Wang Q, Mei L, Xiong WC (2001) Inhibition of PYK2-induced actin cytoskeleton reorganization, PYK2 autophosphorylation and focal adhesion targeting by FAK.J Cell Sci 114:2977-2987
12. Stanzione R, Picascia A, Chieffi P et al. (2001) Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression. Lab Invest 81:51-59
13. Liu ZY, Ganju RK, Wang JF et al. (1997) Cytokine signaling through the novel tyrosine kinase RAFTK in Kaposi's sarcoma cells. J Clin Invest 99:1798-1804
14. Zrihan-Licht S, Fu Y, Settleman J et al. (2000) RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion. Oncogene 19:1318-1328
15. Ludwig HC, Akhavan-Shigari R, Rausch S, Schallock K, Quentin C, Bockermann V, Kolenda H (2000) Expression of focal adhesion kinase (p125 FAK) and proline-rich tyrosine kinase 2 (PYK2/CAKb) in cerebral metastases, correlation with VEGF-R-, ecNOS III-labelling and morphometric data. Anticancer Res 20:1419-1424
16. Wu CJ, Yang XF, McLaughlin S et al. (2000) Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia. J Clin Invest 106:705 -714
17. Brunton VG, Ozanne BW, Paraskeva C, Frame MC (1997) A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer. Oncogene 14:283-293
18. Brunton VG, Fincham VJ, McLean GW, Winder SJ, Paraskeva C, Marshall JF, Frame MC (2001) The protrusive phase and full development of integrin-dependent adhesions in colon epithelial cells require fak- and erk-mediated actin spike formation: deregulation in cancer cells. Neoplasia 3:215-226
19. Weiner TM, Liu ET, Craven RJ, Cance WG (1993) Expression of focal adhesion kinase gene and invasive cancer. Lancet 342:1024-1025
20. Weiner TM, Liu ET, Craven RJ, Cance WG (1994) Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors. Ann Surg Oncol 1:18-27
21. Cance WG, Harris JE, Iacocca MV et al. (2000) Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res 6:2417-2423
22. Agochiya M, Brunton VG, Owens DW, Parkinson EK, Paraskeva C, Keith WN, Frame MC (1999) Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene 18:5646-5653
23. Avraham S, Avraham H (1997) Characterization of the novel focal adhesion kinase RAFTK in hematopoietic cells. Leuk Lymphoma 27:247-256
24. Chauhan D, Hideshima T, Pandey P et al. (1999) RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells. Oncogene 18:6733-6740
25. Pandey P, Avraham S, Place A et al. (1999) Bcl-xL blocks activation of related adhesion focal tyrosine kinase/proline-rich tyrosine kinase 2 and stress-activated protein kinase/ dun N-terminal protein kinase in the cellular response to methylmethane sulfonate. J Biol Chem 274:8618-8623.
26. Pandey P, Avraham S, Kumar S et al. (1999) Activation of p38 mitogen-activated protein kinase by PYK2/related adhesion focal tyrosine kinase-dependent mechanism. J Biol Chem 274:10140-10144
27. Susa M (1999) Heterotrimeric G proteins as fluoride targets in bone (review). Int J Mol Med 3:115-126
28. Xiong W, Parsons JT (1997) Induction of apoptosis after expression of PYK2, a tyrosine kinase structurally related to focal adhesion kinase. J Cell Biol 139:529-S39
29. Cary LA, Guan JL (1999) Focal adhesion kinase in integrin-mediated signaling. Front Biosci 4:D102-113
30. Kornberg LJ (1998) Focal adhesion kinase and its potential involvement in tumor invasion and metastasis. Head Neck 20:745-752
31. Owens LV, Xu L, Dent GA, Yang X, Sturge GC, Craven RJ, Cance WG (1996) Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer. Ann Surg Oncol 3:100-105
32. Judson PL, He X, Cance WG, Van Le L (1999) Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma. Cancer 86:1551-1556
33. Rodina A, Schramm K, Musatkina E, Kreuser ED, Tavitian A, Tatosyan A (1999) Phosphorylation of p125FAK and paxillin focal adhesion proteins in src-transformed cells with different metastatic capacity. FEBS Lett 455:145-148
34. Ilic D, Genbacev O, Jin F et al. (2001) Plasma membrane-associated pY397FAK is a marker of cytotrophoblast invasion in vivo and in vitro. Am J Pathol 159:93-108